Profile: Most Low-Risk Prostate Cancer Patients Receive Aggressive Treatment

Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered ‘normal.’ New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No…

More: continued here

Filed under: Cancer on July 27th, 2010